IMMUNOTHERAPIES
FOR HUMANS,
BIOFACTURED
IN PLANTS
Plant-based
peptide drugs
Proven on animals
for Rheumatoid Arthritis
Re-education
of the human immune system
Plant-based
peptide drugs
Proven on animals
for Rheumatoid Arthritis
Re-education
of the human immune system
FIRST APPLICATION
The first asset from our platform is a Specific Rheumatoid Arthritis Drug based on the restoration of self-tolerance, safer, scalable, and cost-effective.
PROBLEM
Rheumatoid Arthritis
Actual Drugs cause general Immunosuppression and severe side effects
20% of the patients do not respond to any drug in use
SOLUTION
The first assets from our platform is a Specific Rheumatoid Arthritis Drug based on the restoration of self-tolerance
We expect them to enter the clinic in 2024
No side effects; maintaining the immune system’s ability to defend itself
Plant-based
Safer, scalable and cost-effective
AWARDS
2015
StartCup Veneto award, third prize
2015
PNI Cosenza award, and get the opportunity to participate in the acceleration program of Unicredit Start Lab and Fondazione Filarete
2016
Premio Marisa Bellisario, Germoglio d’Oro
2016
Premio startup Gaetano Marzotto, and get the opportunity to participate in the acceleration program of Bio-Industry Park Silvano Fumerio, Torino e and in the acceleration program Z-Cube;
2017
EIT Health award, finalist
(€ 7.000)
(€ 7.000)
2017
Global Social Startup Competition, special mention
2017
Donne e Lavoro prize (5000€)
2018
Gamma Donna prize, finalist
2018
Lean In EU Women Business Angels Prize
2020-2021
Mass Challenge Houston acceleration program, Global Startup Competition
2021
B-Factor prize, Fondazione Marisa Bellisario
2022
Participation in the acceleration program in Israele, Global Startup Competition
2022
Participation in the acceleration program of LeVillage Triveneto, “Investiamo nel Futuro”
2022
EIT HEALTH Innostars Award, finalist
2022
Well4Tech 2022, Connecticut, second prize
INVESTOR
Angels for Women
Arieli Capital
Fondazione Golinelli
